局麻药温度对硬膜外分娩镇痛产时发热的影响:随机临床试验
这项双盲随机对照试验纳入220名初产妇,比较37°C与22°C局麻药用于硬膜外分娩镇痛。最高体温也较低,寒战发生率无差异,次要结局均无显著差异。
要点
- 37°C加温局麻药使产时发热风险减半,但未达预设60%临床意义阈值。
- 加温组最高体温中位数降低0.2°C,寒战发生率无显著差异。
- 镇痛起效、阻滞平面、产程、新生儿结局及母体不良事件均无显著差异。
核心结论
- 使用37°C加温局麻药进行硬膜外分娩镇痛可使产时发热发生率降低约50%,但未达到预设的60%降幅临床意义阈值。
研究设计与样本
- 双盲随机对照试验,纳入220名18-35岁、ASA II级、足月初产产妇,随机分为37°C加温组(n=110)和22°C室温组(n=110)。
主要发现
- 次要结局包括镇痛起效、阻滞平面、局麻药用量、产程、新生儿Apgar评分、脐血pH和BE、母体不良事件,组间均无统计学显著差异。
关键数值与推荐
- 硬膜外方案:0.075%罗哌卡因+0.5 µg/mL舒芬太尼,L3-L4穿刺,试验剂量3 mL 1.5%利多卡因(室温),程序化间歇硬膜外推注(初始10 mL,10 mL/h),PCEA 5 mL,锁定时间30分钟。
- 产时发热定义:鼓膜温度≥38°C,从硬膜外置管至分娩每30分钟测量一次。
- 主要结局为发热发生率,并基于此进行功效分析;预设临床意义差异为60%降幅。
临床怎么用
- 对接受硬膜外分娩镇痛的初产妇,可考虑将局麻药加温至37°C以降低产时发热风险。
- 加温局麻药未显著增加不良反应,且不延长产程或影响新生儿结局。
局限性
- 发热发生率降低未达预设60%临床意义阈值,需更大样本验证临床获益。
- 单中心研究,仅纳入足月初产、ASA II级产妇,外推性受限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Whether heating local anesthetic solutions to core body temperature (37°C) for epidural labor analgesia reduces intrapartum fever incidence remains undefined in the current literature. METHODS: This double-blind randomized controlled trial (RCT) enrolled 220 nulliparous parturients (18-35 years, American Society of Anesthesiologists [ASA] physical status II, term singleton pregnancy). Participants were randomized to receive epidural labor analgesia with 0.075% ropivacaine + 0.5 µg/mL sufentanil at 37°C (warmed group) or 22°C (room-temperature group). Epidurals were placed at L3-L4 with a test dose of 3 mL of 1.5% lidocaine at room temperature, followed by programmed bolus epidural analgesia (initial 10 mL, 10 mL/h) and patient-controlled epidural analgesia (PCEA) 5 mL (30-minute lockout). Tympanic temperature was measured every 30 minutes from epidural initiation to delivery, defining intrapartum fever as ≥38°C. The primary outcome was fever incidence, on which the power analysis was based, and also maximum temperature and shivering. Secondary outcomes comprised analgesia onset, block level, labor durations, neonatal Apgar scores, umbilical cord blood pH and BE, and maternal adverse events. RESULTS: A total of 220 parturients were included (warmed group, n = 110; room-temperature group, n = 110). The warmed group had a lower intrapartum fever incidence (15.5% [17/110] vs 30.9% [34/110], relative risk [RR] 0.5 [95% confidence interval {CI}, 0.298-0.840]; P = .007); however, the reduction of 49.8% did not reach the preset clinically meaningful difference of 60% reduction proposed in the power analysis. The maximum body temperature was also lower in the warmed group: median (interquartile range [IQR]) 37.4 (IQR, 37.2-37.7) °C vs 37.6 (IQR, 37.3-38.0) °C, median difference -0.2 (95% CI, -0.3 to -0.1) °C ( P = .006). Shivering incidence was not different between groups (10.9% [12/110] vs 14.5% [16/110]; P = .418). No statistically significant differences were observed between groups in any of the secondary outcomes assessed, including block characteristics, local anesthetic consumption, labor duration, neonatal outcomes, and maternal adverse events. CONCLUSION: Although we found a 50% reduction in the incidence of temperature rise using warmed (37°C) local anesthetics for epidural labor analgesia, this did not reach our preset threshold of 60% reduction.
引用
- Wei HC, Cao Y, Wu XY, et al. Effect of Local Anesthetic Solution at Different Temperatures for Epidural Labor Analgesia on Intrapartum Fever: A Randomized Clinical Trial. Anesth Analg. 2026. PMID: 41944846. doi:10.1213/ANE.0000000000008041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。